Yagantra
Investors

Thailand's medical herb industry runs on paper. Yagantra is changing that.

The record system for a regulated market heading to $2.5B — traceability, patient limits, and DTAM reporting on one platform.

11,136

licensed dispensaries (DTAM, Feb 2026)

85%

of operators failed license renewal in 2025

$2.5B

Thai market estimate by 2028

The problem

The market was legalized. The infrastructure never followed.

  1. 2022–2024

    The boom

    Legalization triggers a gold rush: 11,000+ dispensaries and 11,800+ cultivation operators enter the market.

  2. June 2025

    The rules arrive

    Flower becomes a controlled herb. PT.33 prescriptions, monthly PT.27/PT.28/PT.29 filings, and GACP become mandatory.

  3. 2025

    The reckoning

    Only 1,339 of 8,636 operators — 15.5% — pass license renewal. 85% fail, largely on paperwork they couldn't produce.

  4. 2026

    The consolidation

    4,587 licenses expire this year, 5,210 more in 2027. Since April 2026, ~11,000 dispensaries must convert into regulated medical clinics with digital recordkeeping.

Through all of this, not a single compliance platform exists on the market. Operators run a controlled substance on paper and Excel.

Solution

One record system for the entire industry chain

Every actor's operations write into one immutable record — so traceability, patient limits, and regulatory reports are by-products of daily work, not month-end projects.

Farm

Harvest & batch records

Lab

Tests & certificates

Dispensary

Sales & PT.33 limits

Doctor

Electronic prescriptions

Patient

Verified purchases

YAGANTRA

One record from strain to sale · Automated DTAM reports · Patient limits enforced network-wide

Track & trace

Full genealogy of every batch — from strain to sold package.

Automated DTAM reporting

PT.27/PT.28/PT.29 generate from real operations. A farm's three days of paperwork becomes seconds.

Network-wide PT.33 limits

Real-time checks on patient purchases across every dispensary.

Immutable audit trail

Append-only, hash-chained records — inspector-ready at any moment.

Why Thailand

The only market of its kind in Southeast Asia

Legal and alone

Thailand is the only legal medical cannabis market in Southeast Asia — first mover in a region of 680 million people.

The ASEAN playbook

Whoever builds the compliance layer for Thailand owns the template for every ASEAN market that follows.

Paper everywhere

The least digitized regulated market anywhere: mandatory reporting, zero tooling. Maximum opening for the first platform.

Market

Who our customers are

Dispensaries

11,136

licensed today — converting to regulated medical clinics since April 2026

Farms

217 GACP

certified today, out of 11,800+ growers who need certification to survive renewal

Labs & doctors

Every batch

requires lab testing; 8 categories of licensed practitioners can issue PT.33

$2.5B

Thai market estimate by 2028

4,587

licenses up for renewal in 2026 — a hot audience right now

Sales model — B2B + B2G. No full-cycle local competitor exists.
Marketplace

A second revenue stream built into the chain

Beyond subscriptions, Yagantra operates the closed B2B marketplace where the industry actually trades.

Farm → dispensary, direct

Verified counterparties trade without middlemen — spot sales and forward contracts against future harvests.

Export track

Australia's April 2026 rules require farm-to-package traceability. Yagantra generates it automatically — international buyers reach GACP farms directly.

Transaction economics

Every trade flows through the platform with full genealogy — a natural base for transaction fees as volume grows.

The government angle

Built to become national infrastructure

The regulator needs exactly what the platform produces.

DTAM sees the market in real time

Aggregated, anonymized market data — free for the regulator, generated as a by-product of operators' daily work.

A national track & trace candidate

Thailand has no state traceability system. A platform already covering the chain is the natural candidate — think private infrastructure for a mandatory market, like Visa for payments.

TCCI — first in Asia

The Thailand Cannabis Compliance Index: market-wide pricing, volume, and compliance data no one else can assemble. Licensable to exchanges and analysts.

A moat made of data

None of this can be copied without the operational data underneath. Every month of operation widens the gap.

Competition

Why this stays ours

Why won't DTAM build it?

Governments regulate; they don't build and operate commercial SaaS. Globally, track & trace for regulated markets is run by private vendors (METRC in the US) — the state consumes the data.

Why won't someone copy it?

The software can be copied; the accumulated genealogy data, verified network, and switching costs can't. In infrastructure, the first mover with the network takes the market.

Why not a local IT company?

The barrier isn't code — it's regulatory depth and industry trust. We have a Thai regulatory expert working directly with DTAM and are already inside the licensing process with our first farm.

Business model

Monthly SaaS subscription

Each customer enables the modules they need and pays a fixed monthly fee. Figures from our financial model, base scenario.

Unit economics in one line

500 dispensaries × ฿2,000 + 50 farms × ฿8,000 = ฿1.4M MRR (~$41K/mo)

Dispensaries and farms alone; labs and doctors add on top. That's 4.5% of today's licensed dispensaries.

Farm

from฿8,000/mo

LTV ~฿600K

  • Track & trace
  • Marketplace & export
  • DTAM reporting

Dispensary

from฿2,000/mo

LTV ~฿150K

  • Track & trace
  • PT.33 limits
  • DTAM reporting

Lab

from฿1,500/mo

LTV ~฿115K

  • Certificates
  • DTAM reporting

Doctor

from฿1,000/mo

LTV ~฿75K

  • PT.33 prescriptions
  • Patient history

LTV at 15% annual churn (~6.5-year average customer life).

Financial model — base scenario, 5 years

฿24M

Year-5 revenue (from ฿0.4M in Year 1)

฿15M

Year-5 EBITDA

~365

active customers by Year 5

฿2.2M

MRR at end of Year 5

Apr 2028

monthly break-even — 22 months after development start

Nov 2029

full payback of capital

Funding rounds

Pre-seed (Angel)

Now

฿2.1M · $62K

Jun 2026 — open now

Instrument: SAFE

MVP development, company registration, legal retainer

Seed Extension

฿2.4M · $70K

Nov 2026

Instrument: SAFE follow-on

Extend runway to paid launch and first hires

Series Seed

฿4.5M · $133K

Mar 2027

Instrument: Priced round

Path to break-even, scale features and growth

Total raise ~฿9M (~$265K) — enough to reach self-sufficiency with a buffer.
Product roadmap

A platform, not a point solution

01

MVP

Flower chain end to end — Oct 2026

02

Full platform

Genetics, nursery, extracts — 2027

03

Marketplace

Contracts, pre-orders, POS — H1 2027

04

Export track

Australia-ready documentation — 2027

05

TCCI index

First market index in Asia — H2 2027

06

ASEAN

New jurisdictions — 2028+

Team

Who is building Yagantra

R

Roman Tuturov

Product Lead · Co-founder

  • Product management; took two B2B SaaS products from zero to launch
  • Built and managed standart operations procedures of a GACP-compliant farm
  • Owns product, strategy, and fundraising
A

Andrey Rozanov

Tech Lead · Co-founder

  • Software engineering; shipped SaaS platforms end to end as founding engineer
  • Designed and managed the operations of a GACP-compliant farm
  • Led development teams from prototype to production
  • Owns product architecture
A

Ann

Regulatory Expert · Thailand

  • Works directly with DTAM on licensing and reporting requirements
  • Guides farms through GACP certification
  • Thai-language regulatory documentation and filings
Proof of execution: we are already guiding our first farm through GACP certification.
Why now

The window is open — but not for long

The market is consolidating right now. Whoever builds the infrastructure first owns it.

01

Compliance became mandatory in June 2025

A concrete regulation with concrete forms: PT.33, PT.27/PT.28/PT.29, GACP. The draft Cannabis & Hemp Act now in parliament only points one way — tighter.

02

85% of operators failed renewal

Only 1,339 of 8,636 passed in 2025. The market's biggest pain is exactly the thing we automate.

03

4,587 licenses expire in 2026

Plus 5,210 in 2027 — every renewal must meet the new requirements. This audience is looking for tooling right now.

04

There is no compliance platform

Not one full-cycle system on the market — and building one requires regulatory depth and industry trust that take years to accumulate.

05

Thailand first, then ASEAN

The first mover here writes the playbook for the region — like Visa and Mastercard: private infrastructure for a mandatory market.

Exit paths

Several ways this pays back

Strategic M&A

Acquisition by a Thai pharma group or healthcare holding entering the regulated market.

Data licensing

TCCI market data licensed to SET, Bloomberg, and industry analysts.

IPO on SET

A listing on the Stock Exchange of Thailand as the market's infrastructure layer.

State partnership

A formal track & trace partnership with DTAM anchoring the platform as national infrastructure.